Aristeia Capital’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.32M Hold
490,750
0.11% 139
2025
Q4
$5.25M Hold
490,750
0.11% 116
2025
Q3
$5.2M Hold
490,750
0.12% 108
2025
Q2
$5.18M Sell
490,750
-9,250
-2% -$96.7K 0.14% 106
2025
Q1
$5.15M Hold
500,000
0.13% 98
2024
Q4
$5.07M Hold
500,000
0.17% 90
2024
Q3
$5.04M Buy
+500,000
New +$5.01M 0.1% 64

Other funds holding GPAT

Aristeia Capital's GPAT Position: Q1 2026 in Review

Aristeia Capital held its GP-Act III Acquisition Corp (GPAT) position steady in Q1 2026 at 490,750 shares worth $5.32M. The position accounts for 0.11% of the portfolio, ranked #139.

Aristeia Capital first reported a position in GPAT in Q3 2024 and has held it in 7 quarters since. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • Aristeia Capital held 490,750 shares of GP-Act III Acquisition Corp worth $5.32M as of Q1 2026.
  • Aristeia Capital left its GP-Act III Acquisition Corp share count unchanged in Q1 2026.
  • GP-Act III Acquisition Corp made up 0.11% of Aristeia Capital's portfolio in Q1 2026, its #139 holding.
  • Aristeia Capital first reported a position in GP-Act III Acquisition Corp in Q3 2024 and has held it in 7 quarters since.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on Aristeia Capital's 13F filing for Q1 2026, filed 15 May 2026.